130 related articles for article (PubMed ID: 10775459)
1. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site.
Iber H; Chen Q; Cheng PY; Morgan ET
Arch Biochem Biophys; 2000 May; 377(1):187-94. PubMed ID: 10775459
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.
Chen JQ; Ström A; Gustafsson JA; Morgan ET
Mol Pharmacol; 1995 May; 47(5):940-7. PubMed ID: 7538197
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the proximal promoter and two silencer elements in the CYP2C11 gene expressed in rat liver.
Ström A; Eguchi H; Mode A; Legraverend C; Tollet P; Strömstedt PE; Gustafsson JA
DNA Cell Biol; 1994 Aug; 13(8):805-19. PubMed ID: 8068205
[TBL] [Abstract][Full Text] [Related]
4. Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.
Cheng PY; Wang M; Morgan ET
J Pharmacol Exp Ther; 2003 Dec; 307(3):1205-12. PubMed ID: 14557382
[TBL] [Abstract][Full Text] [Related]
5. IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene.
Buggs C; Nasrin N; Mode A; Tollet P; Zhao HF; Gustafsson JA; Alexander-Bridges M
Mol Endocrinol; 1998 Sep; 12(9):1294-309. PubMed ID: 9731699
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CYP2C11 by dehydroepiandrosterone and peroxisome proliferators: identification of the negative regulatory region of the gene.
Ripp SL; Falkner KC; Pendleton ML; Tamasi V; Prough RA
Mol Pharmacol; 2003 Jul; 64(1):113-22. PubMed ID: 12815167
[TBL] [Abstract][Full Text] [Related]
7. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11.
Nikolova-Karakashian M; Morgan ET; Alexander C; Liotta DC; Merrill AH
J Biol Chem; 1997 Jul; 272(30):18718-24. PubMed ID: 9228043
[TBL] [Abstract][Full Text] [Related]
8. Role of NF-κB in cytochrome P450 epoxygenases down-regulation during an inflammatory process in astrocytes.
Navarro-Mabarak C; Mitre-Aguilar IB; Camacho-Carranza R; Arias C; Zentella-Dehesa A; Espinosa-Aguirre JJ
Neurochem Int; 2019 Oct; 129():104499. PubMed ID: 31271766
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes.
Chen J; Nikolova-Karakashian M; Merrill AH; Morgan ET
J Biol Chem; 1995 Oct; 270(42):25233-8. PubMed ID: 7559661
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation.
Iber H; Li-Masters T; Chen Q; Yu S; Morgan ET
J Pharmacol Exp Ther; 2001 Apr; 297(1):174-80. PubMed ID: 11259542
[TBL] [Abstract][Full Text] [Related]
11. cDNA-directed expression of two allelic variants of cytochrome P450 2C11 using COS1 and SF21 insect cells.
Biagini C; Celier C
Arch Biochem Biophys; 1996 Feb; 326(2):298-305. PubMed ID: 8611037
[TBL] [Abstract][Full Text] [Related]
12. Attenuated expression of episodic growth hormone-induced CYP2C11 in female rats associated with suboptimal activation of the Jak2/Stat5B and other modulating signaling pathways.
Dhir RN; Thangavel C; Shapiro BH
Drug Metab Dispos; 2007 Nov; 35(11):2102-10. PubMed ID: 17682071
[TBL] [Abstract][Full Text] [Related]
13. Nominal growth hormone pulses in otherwise normal masculine plasma profiles induce intron retention of overexpressed hepatic CYP2C11 with associated nuclear splicing deficiency.
Pampori NA; Shapiro BH
Endocrinology; 2000 Nov; 141(11):4100-6. PubMed ID: 11089541
[TBL] [Abstract][Full Text] [Related]
14. Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.
Lee SH; Wang X; DeJong J
Nucleic Acids Res; 2000 May; 28(10):2091-8. PubMed ID: 10773077
[TBL] [Abstract][Full Text] [Related]
15. Suppression of constitutive cytochrome P450 gene expression by epidermal growth factor receptor ligands in cultured rat hepatocytes.
Ching KZ; Tenney KA; Chen J; Morgan ET
Drug Metab Dispos; 1996 May; 24(5):542-6. PubMed ID: 8723734
[TBL] [Abstract][Full Text] [Related]
16. Expression of a male-specific cytochrome P450 isozyme (CYP2C11) in fa/fa Zucker rats: effect of phenobarbital treatment.
Bandyopadhyay AM; Chaudhary I; Robertson LW; Gemzik B; Parkinson A; Blouin RA
Arch Biochem Biophys; 1993 Dec; 307(2):386-90. PubMed ID: 8274026
[TBL] [Abstract][Full Text] [Related]
17. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-1 motif and redundant regulatory elements comprise phenobarbital-responsive enhancer in CYP2B1/2.
Liu S; Park Y; Rivera-Rivera I; Li H; Kemper B
DNA Cell Biol; 1998 May; 17(5):461-70. PubMed ID: 9628589
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes.
Sewer MB; Morgan ET
Biochem Pharmacol; 1997 Sep; 54(6):729-37. PubMed ID: 9310350
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional suppression of cytochrome P450 2C11 gene expression by 3-methylcholanthrene.
Lee C; Riddick DS
Biochem Pharmacol; 2000 Jun; 59(11):1417-23. PubMed ID: 10751551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
